A SBIR Phase II contract was awarded to Soligenix in December, 2020 for $636,664.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A SBIR Phase II contract was awarded to Soligenix in September, 2017 for $1,500,000.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase II contract was awarded to Soligenix in September, 2017 for $1,464,817.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Soligenix for $225,000.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Soligenix for $470,535.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Soligenix for $149,912.0 USD from the U.S. Department of Health & Human Services.